tirzépatide nom commercial Mounjaro (tirzépatide) : nouveau traitement contre l'obésité et le diabète SofortArzt | Mounjaro®

To gauge its safety and effectiveness in young people, scientists recruited 99 patients between the ages of 10 and 17 who had poorly controlled obesity and Type 2 diabetes despite being on treatments like metformin and/or insulin

Tirzepatide is one of the most popular GLP-1 agonists

This shift in taste can be unsettling

The FDA has approved tirzepatide (as Zepbound for weight management and Mounjaro for type 2 diabetes) at standard doses starting at 2.5 mg weekly

Many competitors offer extended hours, chat support, or at minimum, a robust FAQ and self-service portal

The oral contraceptive pill Mounjaro is known to make the oral contraceptive pill work less effectively